Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis. / Clausen, Frederik Banch; Rieneck, Klaus; Krog, Grethe Risum; Bundgaard, Birgitte Suhr; Dziegiel, Morten Hanefeld.

Prenatal Diagnosis. ed. / Brynn Levy. Humana Press, 2019. p. 347-359 (Methods in Molecular Biology, Vol. 1885).

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Clausen, FB, Rieneck, K, Krog, GR, Bundgaard, BS & Dziegiel, MH 2019, Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis. in B Levy (ed.), Prenatal Diagnosis. Humana Press, Methods in Molecular Biology, vol. 1885, pp. 347-359. https://doi.org/10.1007/978-1-4939-8889-1_23

APA

Clausen, F. B., Rieneck, K., Krog, G. R., Bundgaard, B. S., & Dziegiel, M. H. (2019). Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis. In B. Levy (Ed.), Prenatal Diagnosis (pp. 347-359). Humana Press. Methods in Molecular Biology Vol. 1885 https://doi.org/10.1007/978-1-4939-8889-1_23

Vancouver

Clausen FB, Rieneck K, Krog GR, Bundgaard BS, Dziegiel MH. Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis. In Levy B, editor, Prenatal Diagnosis. Humana Press. 2019. p. 347-359. (Methods in Molecular Biology, Vol. 1885). https://doi.org/10.1007/978-1-4939-8889-1_23

Author

Clausen, Frederik Banch ; Rieneck, Klaus ; Krog, Grethe Risum ; Bundgaard, Birgitte Suhr ; Dziegiel, Morten Hanefeld. / Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis. Prenatal Diagnosis. editor / Brynn Levy. Humana Press, 2019. pp. 347-359 (Methods in Molecular Biology, Vol. 1885).

Bibtex

@inbook{9694f3afbc4a4d00af22dec74b45ad10,
title = "Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis",
abstract = "RhD negative pregnant women who carry an RhD positive fetus are at risk of immunization against the D antigen, which may result in hemolytic disease of the fetus and the newborn. Predicting the fetal RhD status by noninvasive antenatal screening for the fetal RhD gene (RHD) can guide targeted use of antenatal anti-D prophylaxis. Cell-free fetal DNA is extracted from maternal plasma from RhD negative pregnant women at a gestational age of 25 weeks. A real-time PCR-based detection of two RHD exons enables reliable prediction of the fetal RhD status to determine the administration of antenatal prophylaxis, as well as postnatal prophylaxis.",
keywords = "Antenatal prophylaxis, Anti-D, Cell-free fetal DNA, Hemolytic disease of the fetus and newborn, Noninvasive RHD typing, Real-time PCR",
author = "Clausen, {Frederik Banch} and Klaus Rieneck and Krog, {Grethe Risum} and Bundgaard, {Birgitte Suhr} and Dziegiel, {Morten Hanefeld}",
year = "2019",
doi = "10.1007/978-1-4939-8889-1_23",
language = "English",
isbn = "978-1-4939-8887-7",
series = "Methods in Molecular Biology",
publisher = "Humana Press",
pages = "347--359",
editor = "Brynn Levy",
booktitle = "Prenatal Diagnosis",
address = "United States",

}

RIS

TY - CHAP

T1 - Noninvasive antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis

AU - Clausen, Frederik Banch

AU - Rieneck, Klaus

AU - Krog, Grethe Risum

AU - Bundgaard, Birgitte Suhr

AU - Dziegiel, Morten Hanefeld

PY - 2019

Y1 - 2019

N2 - RhD negative pregnant women who carry an RhD positive fetus are at risk of immunization against the D antigen, which may result in hemolytic disease of the fetus and the newborn. Predicting the fetal RhD status by noninvasive antenatal screening for the fetal RhD gene (RHD) can guide targeted use of antenatal anti-D prophylaxis. Cell-free fetal DNA is extracted from maternal plasma from RhD negative pregnant women at a gestational age of 25 weeks. A real-time PCR-based detection of two RHD exons enables reliable prediction of the fetal RhD status to determine the administration of antenatal prophylaxis, as well as postnatal prophylaxis.

AB - RhD negative pregnant women who carry an RhD positive fetus are at risk of immunization against the D antigen, which may result in hemolytic disease of the fetus and the newborn. Predicting the fetal RhD status by noninvasive antenatal screening for the fetal RhD gene (RHD) can guide targeted use of antenatal anti-D prophylaxis. Cell-free fetal DNA is extracted from maternal plasma from RhD negative pregnant women at a gestational age of 25 weeks. A real-time PCR-based detection of two RHD exons enables reliable prediction of the fetal RhD status to determine the administration of antenatal prophylaxis, as well as postnatal prophylaxis.

KW - Antenatal prophylaxis

KW - Anti-D

KW - Cell-free fetal DNA

KW - Hemolytic disease of the fetus and newborn

KW - Noninvasive RHD typing

KW - Real-time PCR

U2 - 10.1007/978-1-4939-8889-1_23

DO - 10.1007/978-1-4939-8889-1_23

M3 - Book chapter

C2 - 30506209

AN - SCOPUS:85058170091

SN - 978-1-4939-8887-7

T3 - Methods in Molecular Biology

SP - 347

EP - 359

BT - Prenatal Diagnosis

A2 - Levy, Brynn

PB - Humana Press

ER -

ID: 223453130